IDEAYA Biosciences (IDYA) Prepaid Assets (2018 - 2026)
IDEAYA Biosciences' (IDYA) quarterly Prepaid Assets came in at $18.3 million in Q1 2026, up 19.41% year-on-year from $15.4 million in Q1 2025, and down 14.13% quarter-over-quarter from $21.4 million in Q4 2025.
IDEAYA Biosciences (IDYA) Prepaid Assets (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has disclosed Prepaid Assets across 9 years of filings, most recently posting $18.3 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $18.3 million, up 19.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.3 million (up 19.41% YoY), and the FY2025 annual result was $21.4 million, up 59.52% from the prior year.
- Prepaid Assets came in at $18.3 million for Q1 2026 at IDEAYA Biosciences, down from $21.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $21.4 million in Q4 2025 to a low of $2.8 million in Q1 2022.
- The 5-year median for Prepaid Assets is $10.6 million (2024), against an average of $10.3 million.
- Across the five-year window, Prepaid Assets retreated 23.48% in 2022 and surged 162.84% in 2024, its largest moves.
- IDEAYA Biosciences' Prepaid Assets stood at $5.4 million in 2022, then surged by 38.53% to $7.5 million in 2023, then surged by 78.59% to $13.4 million in 2024, then surged by 59.52% to $21.4 million in 2025, then decreased by 14.13% to $18.3 million in 2026.
- The last three Prepaid Assets figures came in at $18.3 million (Q1 2026), $21.4 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.35 Mn |
| Dec 31, 2025 | 21.37 Mn |
| Sep 30, 2025 | 15.76 Mn |
| Jun 30, 2025 | 15.86 Mn |
| Mar 31, 2025 | 15.36 Mn |
| Dec 31, 2024 | 13.39 Mn |
| Sep 30, 2024 | 12.17 Mn |
| Jun 30, 2024 | 11.52 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 6.73 Mn |
| Jun 30, 2023 | 7.91 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 5.41 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 4.29 Mn |